Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 148,011 | 131,973 | 68,131 | 218,044 | 118,615 |
| Marketable Securities | 961,245 | 1,059,014 | 1,220,322 | 1,118,171 | 987,440 |
| TOTAL | $1,142,884 | $1,224,062 | $1,325,162 | $1,372,319 | $1,138,526 |
| Non-Current Assets | |||||
| PPE Net | 48,101 | 39,821 | 42,117 | 44,087 | 41,692 |
| Investments And Advances | 7,905 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 37,887 | 41,851 | 42,065 | 43,836 | 47,388 |
| TOTAL | $93,893 | $81,672 | $84,182 | $87,923 | $89,080 |
| Total Assets | $1,236,777 | $1,305,734 | $1,409,344 | $1,460,242 | $1,227,606 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,182 | 8,520 | 2,215 | 2,790 | 7,539 |
| Accrued Expenses | 36,286 | 35,986 | 76,666 | 66,691 | 40,828 |
| Other current liabilities | 26,698 | 18,077 | 305,660 | 294,441 | 305,235 |
| TOTAL | $71,180 | $69,357 | $391,080 | $363,922 | $360,670 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 47,266 | 49,552 | 51,558 | 53,890 | 55,633 |
| TOTAL | $47,266 | $49,552 | $51,558 | $53,890 | $55,633 |
| Total Liabilities | $118,446 | $118,909 | $442,638 | $417,812 | $416,303 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 138,197 | 137,422 | 136,889 | 136,678 | 135,814 |
| Common Shares | 1,707 | 1,700 | 1,694 | 1,686 | 1,564 |
| Retained earnings | -996,738 | -897,385 | -1,080,768 | -970,987 | -872,309 |
| Other shareholders' equity | -651 | -1,441 | -2,517 | -6,886 | -11,853 |
| TOTAL | $1,118,331 | $1,186,825 | $966,706 | $1,042,430 | $811,303 |
| Total Liabilities And Equity | $1,236,777 | $1,305,734 | $1,409,344 | $1,460,242 | $1,227,606 |